ARCHIVES

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

This article is from The Cancer Letter archive.

Vol. 30 No. 33 | August 13, 2004

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

February 14, 1986

Amgen Web Site For Patients Goes Dark After Story In The Cancer Letter.

November 16, 2007

IOM Omics Committee Offers Blueprint to Prevent Other Duke-Style Disasters

March 23, 2012

House, Senate Meet On Appropriations Bill Differences

October 6, 1989

In Brief: Breast Cancer coalition Plan Rally, Conference; FDA Seeks Information On Unlabeled Drug Uses

April 30, 1993

In Brief: Coltman, Leb Lead ASCO, AACR; Young, Busch Presidents Elect; Renalda Hilkemeyer Honored

June 3, 1988